BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38282747)

  • 21. Efficacy of Extracorporeal Photopheresis in Patients With Bronchiolitis Obliterans Syndrome After Lung Transplantation.
    Pecoraro Y; Carillo C; Diso D; Mantovani S; Cimino G; De Giacomo T; Troiani P; Shafii M; Gherzi L; Amore D; Rendina EA; Venuta F; Anile M
    Transplant Proc; 2017 May; 49(4):695-698. PubMed ID: 28457374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of extracorporeal photopheresis on lung function decline for severe bronchiolitis obliterans syndrome following allogeneic stem cell transplantation.
    Brownback KR; Simpson SQ; Pitts LR; Polineni D; McGuirk JP; Ganguly S; Aljitawi OS; Lin TL; Singh A; Abhyankar S
    J Clin Apher; 2016 Aug; 31(4):347-52. PubMed ID: 26031713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extracorporeal photopheresis for bronchiolitis obliterans syndrome after allogeneic stem cell transplant: An emerging therapeutic approach?
    Del Fante C; Perotti C
    Transfus Apher Sci; 2017 Feb; 56(1):17-19. PubMed ID: 28094112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of extracorporeal photopheresis in clearance of antibodies to donor-specific and lung-specific antigens in lung transplant recipients.
    Baskaran G; Tiriveedhi V; Ramachandran S; Aloush A; Grossman B; Hachem R; Mohanakumar T
    J Heart Lung Transplant; 2014 Sep; 33(9):950-6. PubMed ID: 24906794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Longitudinal lung function measurements in single lung transplant recipients with chronic lung allograft dysfunction.
    Leuschner G; Lauseker M; Howanietz AS; Milger K; Veit T; Munker D; Schneider C; Weig T; Michel S; Barton J; Meiser B; Dinkel J; Neurohr C; Behr J; Kneidinger N
    J Heart Lung Transplant; 2020 Nov; 39(11):1270-1278. PubMed ID: 32917480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulmonary epithelial markers in phenotypes of chronic lung allograft dysfunction.
    Levy L; Moshkelgosha S; Huszti E; Hunter S; Renaud-Picard B; Berra G; Kawashima M; Fernandez-Castillo J; Fuchs E; Dianti M; Ghany R; Keshavjee S; Singer LG; Tikkanen J; Martinu T
    J Heart Lung Transplant; 2023 Aug; 42(8):1152-1160. PubMed ID: 36963446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The efficacy of photopheresis for bronchiolitis obliterans syndrome after lung transplantation.
    Morrell MR; Despotis GJ; Lublin DM; Patterson GA; Trulock EP; Hachem RR
    J Heart Lung Transplant; 2010 Apr; 29(4):424-31. PubMed ID: 19853479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms of Action of Extracorporeal Photopheresis in the Control of Bronchiolitis Obliterans Syndrome (BOS): Involvement of Circulating miRNAs.
    Bozzini S; Del Fante C; Morosini M; Berezhinskiy HO; Auner S; Cattaneo E; Della Zoppa M; Pandolfi L; Cacciatore R; Perotti C; Hoetzenecker K; Jaksch P; Benazzo A; Meloni F
    Cells; 2022 Mar; 11(7):. PubMed ID: 35406680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of early pulmonary function changes after onset of chronic lung allograft dysfunction.
    Todd JL; Neely ML; Finlen Copeland CA; Frankel CW; Reynolds JM; Palmer SM
    J Heart Lung Transplant; 2019 Feb; 38(2):184-193. PubMed ID: 30466803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of chronic rejection after lung transplantation.
    Bedair B; Hachem RR
    J Thorac Dis; 2021 Nov; 13(11):6645-6653. PubMed ID: 34992842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and characterization of chronic lung allograft dysfunction patients with mixed phenotype: A single-center study.
    Verleden SE; Von Der Thüsen J; Van Herck A; Weynand B; Verbeken E; Verschakelen J; Dubbeldam A; Vanaudenaerde BM; Vos R; Verleden GM;
    Clin Transplant; 2020 Feb; 34(2):e13781. PubMed ID: 31958356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of chronic lung allograft dysfunction, especially restrictive allograft syndrome, on the survival after living-donor lobar lung transplantation compared with cadaveric lung transplantation in adults: a single-center experience.
    Sugimoto S; Yamamoto H; Kurosaki T; Otani S; Okazaki M; Yamane M; Toyooka S; Oto T
    Surg Today; 2019 Aug; 49(8):686-693. PubMed ID: 30790054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of a post-transplant chronic lung allograft dysfunction classification system.
    Van Herck A; Verleden SE; Sacreas A; Heigl T; Vanaudenaerde BM; Dupont LJ; Yserbyt J; Verbeken EK; Neyrinck AP; Van Raemdonck D; Verleden GM; Vos R
    J Heart Lung Transplant; 2019 Feb; 38(2):166-173. PubMed ID: 30391199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of long term CD4+CD25highCD127- T-reg cells kinetics in peripheral blood of lung transplant recipients.
    Piloni D; Morosini M; Magni S; Balderacchi A; Scudeller L; Cova E; Oggionni T; Stella G; Tinelli C; Antonacci F; D'Armini AM; Meloni F
    BMC Pulm Med; 2017 Jul; 17(1):102. PubMed ID: 28720146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extracorporeal photopheresis in the treatment of cardiac allograft rejection: A single-centre experience.
    Teszak T; Assabiny A; Kiraly A; Tarjanyi Z; Parazs N; Szakal-Toth Z; Hartyanszky I; Szabolcs Z; Racz K; Reti M; Merkely B; Sax B
    Transpl Immunol; 2023 Aug; 79():101853. PubMed ID: 37196865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peripheral CD4(+)CD25(+) TREG cell counts and the response to extracorporeal photopheresis in lung transplant recipients.
    Meloni F; Cascina A; Miserere S; Perotti C; Vitulo P; Fietta AM
    Transplant Proc; 2007; 39(1):213-7. PubMed ID: 17275508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ECP as additional immunomodulation in idiopathic hyperammonemia and recurrent hypercapnic respiratory failure early post lung transplantation.
    Steinack C; Robinson CA; Nägeli M; Inci I; Benden C
    J Clin Apher; 2021 Feb; 36(1):186-188. PubMed ID: 32838480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction.
    Sato M; Waddell TK; Wagnetz U; Roberts HC; Hwang DM; Haroon A; Wagnetz D; Chaparro C; Singer LG; Hutcheon MA; Keshavjee S
    J Heart Lung Transplant; 2011 Jul; 30(7):735-42. PubMed ID: 21419659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk assessment of chronic lung allograft dysfunction phenotypes: Validation and proposed refinement of the 2019 International Society for Heart and Lung Transplantation classification system.
    Levy L; Huszti E; Renaud-Picard B; Berra G; Kawashima M; Takahagi A; Fuchs E; Ghany R; Moshkelgosha S; Keshavjee S; Singer LG; Tikkanen J; Martinu T
    J Heart Lung Transplant; 2020 Aug; 39(8):761-770. PubMed ID: 32418864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Lymphatic Phenotype of Lung Allografts in Patients With Bronchiolitis Obliterans Syndrome and Restrictive Allograft Syndrome.
    Traxler D; Schweiger T; Schwarz S; Schuster MM; Jaksch P; Lang G; Birner P; Klepetko W; Ankersmit HJ; Hoetzenecker K
    Transplantation; 2017 Feb; 101(2):310-315. PubMed ID: 27163544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.